These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
431 related items for PubMed ID: 33301751
1. Pan-tropomyosin receptor kinase immunoreactivity, ETV6-NTRK3 fusion subtypes, and RET rearrangement in salivary secretory carcinoma. Yamamoto H, Nozaki Y, Sugii A, Taguchi K, Hongo T, Jiromaru R, Sato M, Nakano T, Hashimoto K, Fujiwara M, Oda Y. Hum Pathol; 2021 Mar; 109():37-44. PubMed ID: 33301751 [Abstract] [Full Text] [Related]
2. Pan-TRK Immunohistochemistry Is Highly Correlated With NTRK3 Gene Rearrangements in Salivary Gland Tumors. Csanyi-Bastien M, Lanic MD, Beaussire L, Ferric S, François A, Meseure D, Jardin F, Wassef M, Ruminy P, Laé M. Am J Surg Pathol; 2021 Nov 01; 45(11):1487-1498. PubMed ID: 33899788 [Abstract] [Full Text] [Related]
3. Using pan-TRK and RET Immunohistochemistry for the Detection of Fusion Types of Salivary Gland Secretory Carcinoma. Su YJ, Lee YH, Jin YT, Hsieh MS. Appl Immunohistochem Mol Morphol; 2022 Apr 01; 30(4):264-272. PubMed ID: 35384876 [Abstract] [Full Text] [Related]
4. Immunohistochemistry with a pan-TRK antibody distinguishes secretory carcinoma of the salivary gland from acinic cell carcinoma. Hung YP, Jo VY, Hornick JL. Histopathology; 2019 Jul 01; 75(1):54-62. PubMed ID: 30801752 [Abstract] [Full Text] [Related]
8. Pan-Trk immunohistochemistry is a sensitive and specific ancillary tool for diagnosing secretory carcinoma of the salivary gland and detecting ETV6-NTRK3 fusion. Xu B, Haroon Al Rasheed MR, Antonescu CR, Alex D, Frosina D, Ghossein R, Jungbluth AA, Katabi N. Histopathology; 2020 Feb 01; 76(3):375-382. PubMed ID: 31448442 [Abstract] [Full Text] [Related]
10. Molecular Profiling of Salivary Gland Intraductal Carcinoma Revealed a Subset of Tumors Harboring NCOA4-RET and Novel TRIM27-RET Fusions: A Report of 17 cases. Skálová A, Vanecek T, Uro-Coste E, Bishop JA, Weinreb I, Thompson LDR, de Sanctis S, Schiavo-Lena M, Laco J, Badoual C, Santana Conceiçao T, Ptáková N, Baněčkova M, Miesbauerová M, Michal M. Am J Surg Pathol; 2018 Nov 01; 42(11):1445-1455. PubMed ID: 30045065 [Abstract] [Full Text] [Related]
11. ALK, ROS1 and NTRK3 gene rearrangements in inflammatory myofibroblastic tumours. Yamamoto H, Yoshida A, Taguchi K, Kohashi K, Hatanaka Y, Yamashita A, Mori D, Oda Y. Histopathology; 2016 Jul 01; 69(1):72-83. PubMed ID: 26647767 [Abstract] [Full Text] [Related]
13. Characterization of an ETV6-NTRK3 rearrangement with unusual, but highly significant FISH signal pattern in a secretory carcinoma of the salivary gland: a case report. Wagner F, Greim R, Krebs K, Luebben F, Dimmler A. Diagn Pathol; 2021 Aug 09; 16(1):73. PubMed ID: 34372873 [Abstract] [Full Text] [Related]